Upcoming Panel Discussion, Hosted by Xtalks on Precision Oncology: An Era that Calls for a New Model for Conducting Clinical Trials? Share Article During this discussion, the featured speakers will examine lessons learnt from the clinical development of targeted therapies such as immunotherapeutic agents, and current methodological challenges for new drug development in the precision oncology era. They will provide insights into a novel approach to conduct clinical research in the precision oncology era. Clinical trials have evolved from drug- to target-oriented trials, and this shift has raised several challenges. TORONTO, Ontario (PRWEB) June 04, 2021 Genomic sequencing techniques and bioinformatics have led us to a better understanding of cancer biology, resulting in a shift from empirical strategies to molecular (precision oncology) and immunological therapeutic approaches in clinical oncology. Consequently, clinical trials have evolved from drug- to target-oriented trials, and this shift has raised several challenges.